EquityZen Growth Technology Fund LLC - Series 105 — Form D/A
EquityZen Growth Technology Fund LLC - Series 105 of New York, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2017-07-14. The offering totals $757K, of which $757K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-07-14
- Form: D/A
- Accession: 0001697291-17-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $757K
- Amount sold: $757K
- Investors: 37
- Date of first sale: 2017-04-06
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-285229
Issuer
- Name: EquityZen Growth Technology Fund LLC - Series 105
- CIK: 0001697291
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 10 West 18th St, New York, NY, 10011-4618
- Phone: 8009367943
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| LLC Assure Fund Management II | Director | Salt Lake City, UT |
| Shriram Bhashyam | Director | New York, NY |
| Inc EquityZen | Director | New York, NY |
| Shriram Bhashyam | Executive Officer | New York, NY |
| Inc EquityZen | Executive Officer | New York, NY |
| Erin Rosenthal | Executive Officer | San Francisco, CA |
| Mateo Johnson | Executive Officer | Salt Lake City, UT |
Other filings by this issuer (1)
More